MARKET

ANGN

ANGN

Angion Biomedica Corp.
NASDAQ
0.7000
0.0000
0.00%
Closed 16:00 01/27 EST
OPEN
0.6890
PREV CLOSE
0.7000
HIGH
0.7086
LOW
0.6400
VOLUME
179.22K
TURNOVER
78.64K
52 WEEK HIGH
2.940
52 WEEK LOW
0.5900
MARKET CAP
21.08M
P/E (TTM)
-1.2032
1D
5D
1M
3M
1Y
5Y
Nasdaq Edges Higher; Neovasc Shares Jump
Benzinga · 01/17 19:50
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 01/17 18:21
EH, APPH and ATXI among mid-day movers
Seeking Alpha · 01/17 17:56
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
Benzinga · 01/17 17:07
Neovasc, Aligos top healthcare gainers; Edesa, Angion lead losers' pack
Seeking Alpha · 01/17 15:00
Sibanye Stillwater, iQIYI, Bed Bath & Beyond among premarket losers' pack
Seeking Alpha · 01/17 13:23
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Investor Place · 01/17 12:33
ANGN Crashes Following Merger with Elicio
TipRanks · 01/17 12:28
More
About ANGN
Angion Biomedica Corp. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address chronic and progressive fibrotic diseases. The Company’s products include ANG-3070, ROCK2 Inhibitor, CYP11B2 Inhibitor and ANG-3777. ANG-3070 is a highly selective oral tyrosine kinase receptor inhibitor (TKI) in development as a treatment for fibrotic diseases, particularly in the kidney and lung. The Company provides ANG-3070 for Fibrotic Diseases; ANG-3070 for Renal Fibrosis; ANG-3070 for Pulmonary Fibrosis. ROCK2 Inhibitor program targeted towards the treatment of fibrotic diseases. CYP11B2 Inhibitor program targeted towards diseases related to aldosterone synthase dysregulation. ANG-3777 is designed to mimic the biological activity of HGF and to treat acute organ injuries, such as delayed graft function.

Webull offers kinds of Angion Biomedica Corp stock information, including NASDAQ:ANGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANGN stock methods without spending real money on the virtual paper trading platform.